ArticleBioactive materials2026
Hemoglobin-crosslinked drug-loaded silk fibroin porous scaffold for long-segment tracheal defect repair: An integrated strategy leveraging dynamic mechanical biomimicry and infection control.
Article in Bioactive materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The clinical repair of long-segment tracheal defects (LSTDs) remains a formidable challenge, primarily due to the dynamic mechanical mismatch of current implantable substitutes and high rates of postoperative infection. To address these critical hurdles, we have engineered a novel silk fibroin (SF)-based scaffold, designated Hb-SF@LVX, that simultaneously achieves dynamic mechanical biomimicry and robust infection control. By employing a synergistic dual-crosslinking strategy-combining hemoglobin (Hb)-catalyzed chemical crosslinking with low-temperature-induced β-sheet formation-the scaffold exhibits remarkable elasticity and fatigue resistance, closely mimicking the properties of native tracheal tissue. Furthermore, the scaffold was efficiently loaded with levofloxacin (LVX) and demonstrated prolonged, sustained release, conferring potent antibacterial and
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.